Live Breaking News & Updates on Mmuno Oncology Company Genelux
Stay updated with breaking news from Mmuno oncology company genelux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer. ....